发明名称 |
Triazine derivatives as differentiation catalysts |
摘要 |
A method of inducing differentiation of mammalian cells into cardiomyocyte-like cells by contacting the mammalian cell with a triazine compound of formula (I), wherein X is independently —NR4—or —O—, R4 is hydrogen or C1-6-alkyl; R1 is hydroxy, C1-6-alkyl, C1-6-alkoxy, carboxy, C1-6-alkoxycarbonyl, halo, cyano, nitro, formyl, amino, C1-6-alkylamino, or di-C1-6-alkylamino, the C1-6-alkyl or -alkoxy residue being optionally substituted with one or more R5 substituents selected from hydroxy, halo, cyano, and nitro; n is 0 to 5; R2 is hydrogen, aryl, heteroaryl, or C1-6-alkyl, the aryl or heteroaryl residue being optionally substituted with one or more R1 substituents, and where the C1-6-alkyl is optionally further substituted with one or more R5 substituents; and R3 is selected from hydrogen, halo, NR4R7, OR7, SR7, and R7, where the same options apply for R7 as for R2; with the proviso that the compound of formula (I) is not 3-[(4,6-diphenoxy-1,3,5-triazin-2-yl)amino]benzoic acid. |
申请公布号 |
US9611457(B2) |
申请公布日期 |
2017.04.04 |
申请号 |
US201214346328 |
申请日期 |
2012.09.21 |
申请人 |
TECHNISCHE UNIVERSITAET WIEN |
发明人 |
Mihovilovic Marko;Schnuerch Michael;Hilber Karlheinz;Koenig Xaver;Linder Thomas;Mike Agnes |
分类号 |
C12N5/071;C12N5/077;C07D251/44;C07D251/46;C07D251/48;C07D251/50 |
主分类号 |
C12N5/071 |
代理机构 |
Leydig, Voit & Mayer, Ltd. |
代理人 |
Leydig, Voit & Mayer, Ltd. |
主权项 |
1. A method of inducing differentiation of a mammalian pluripotent stem cell or myoblast cell into a cardiomyocyte-like cell, the method comprising:
incubating the mammalian cell with at least one compound of formula (I)in an amount effective to induce the differentiation,
wherein: X is independently —NR4—or —O—, the R4 being hydrogen or C1-6-alkyl; R1 is hydroxy, C1-6-alkyl, C1-6-alkoxy, carboxy, C1-6-alkoxycarbonyl, halo, cyano, nitro, formyl, amino, C1-6-alkylamino, or di-C1-6-alkylamino, the C1-6-alkyl or -alkoxy being optionally substituted with one or more R5, the R5 being hydroxy, halo, cyano, or nitro; n is 0 to 5; R2 is hydrogen, aryl, heteroaryl, or C1-6-alkyl, the aryl or heteroaryl optionally substituted with one or more R6, identical options applying for R6 as for R1 and the C1-6-alkyl optionally further substituted by one or more R5; and R3 is hydrogen, halo, NR4R7, OR7, SRS, and R7, identical options applying for R7 as for R2, with the proviso that the compound of formula (I) is not 3-[(4,6-diphenoxy-1,3,5-triazin-2-yl)amino]benzoic acid. |
地址 |
Vienna AT |